# Halozyme Therapeutics, Inc.: Form DEF 14A, filed Mar 18, 2025

- Company: [Halozyme Therapeutics, Inc.](/companies/halo.md) (CIK 1159036)
- Form: DEF 14A
- Filed: 2025-03-18
- Accepted by EDGAR: Mar 18, 2025, 16:10 ET
- Period: 2024-12-31
- Accession: 0001159036-25-000016
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000016/halo-20250318.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000016/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1159036/000115903625000016/halo-20250318.htm

Filed Mar 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001159036-25-000016. Last ingested by Listed: Nov 5, 2026, 17:46 ET. No prices; not investment advice.
